DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID ▲ | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0006826 | Malignant Neoplasms | CERS1 | 10715 | ceramide synthase 1 | P27544 |
C0006826 | Malignant Neoplasms | CYP1B1 | 1545 | cytochrome P450 family 1 subfamily B member 1 | Q16678 |
C0006826 | Malignant Neoplasms | CHKA | 1119 | choline kinase alpha | P35790 |
C0006826 | Malignant Neoplasms | CNTN1 | 1272 | contactin 1 | Q12860 |
C0006826 | Malignant Neoplasms | PLAAT3 | 11145 | phospholipase A and acyltransferase 3 | P53816 |
C0006826 | Malignant Neoplasms | CLC | 1178 | Charcot-Leyden crystal galectin | Q05315 |
C0006826 | Malignant Neoplasms | CPT1C | 126129 | carnitine palmitoyltransferase 1C | Q8TCG5 |
C0006826 | Malignant Neoplasms | PIP5KL1 | 138429 | phosphatidylinositol-4-phosphate 5-kinase like 1 | Q5T9C9 |
C0006826 | Malignant Neoplasms | ADH7 | 131 | alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide | P40394 |
C0006826 | Malignant Neoplasms | ADH1A | 124 | alcohol dehydrogenase 1A (class I), alpha polypeptide | P07327 |
C0006826 | Malignant Neoplasms | CYP2B6 | 1555 | cytochrome P450 family 2 subfamily B member 6 | P20813 |
C0006826 | Malignant Neoplasms | CYP3A7 | 1551 | cytochrome P450 family 3 subfamily A member 7 | P24462 |
C0006826 | Malignant Neoplasms | CYP2C19 | 1557 | cytochrome P450 family 2 subfamily C member 19 | P33261 |
C0006826 | Malignant Neoplasms | CYP2E1 | 1571 | cytochrome P450 family 2 subfamily E member 1 | P05181 |
C0006826 | Malignant Neoplasms | CYP2C9 | 1559 | cytochrome P450 family 2 subfamily C member 9 | P11712 |
C0006826 | Malignant Neoplasms | CYP2C8 | 1558 | cytochrome P450 family 2 subfamily C member 8 | P10632 |
C0006826 | Malignant Neoplasms | CYP3A4 | 1576 | cytochrome P450 family 3 subfamily A member 4 | P08684 |
C0006826 | Malignant Neoplasms | CYP2J2 | 1573 | cytochrome P450 family 2 subfamily J member 2 | P51589 |
C0006826 | Malignant Neoplasms | CYP4A11 | 1579 | cytochrome P450 family 4 subfamily A member 11 | Q02928 |
C0006826 | Malignant Neoplasms | CYP19A1 | 1588 | cytochrome P450 family 19 subfamily A member 1 | P11511 |
C0006826 | Malignant Neoplasms | CYP11B2 | 1585 | cytochrome P450 family 11 subfamily B member 2 | P19099 |
C0006826 | Malignant Neoplasms | CYP24A1 | 1591 | cytochrome P450 family 24 subfamily A member 1 | Q07973 |
C0006826 | Malignant Neoplasms | CYP27A1 | 1593 | cytochrome P450 family 27 subfamily A member 1 | Q02318 |
C0006826 | Malignant Neoplasms | DGKB | 1607 | diacylglycerol kinase beta | Q9Y6T7 |
C0006826 | Malignant Neoplasms | DGKG | 1608 | diacylglycerol kinase gamma | P49619 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024